Complete androgen blockade for metastatic prostate cancer.
AUTOR(ES)
Presti, J C
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1022329Documentos Relacionados
- Hormonal therapy for metastatic prostate cancer.
- Complete androgen blockade safely allows for delay of cytotoxic chemotherapy in castration refractory prostate cancer
- Androgen receptor gene mutations in human prostate cancer.
- Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer
- Screening for prostate cancer.